Join us for another episode of the Virtual Breakfast Series where we are joined by Imran Babar, who has been at the forefront of rare disease innovation for over a decade. He was the chief business officer of Cydan, a venture-backed orphan drug accelerator founded in 2013 and was a co-founder and executive for several of the ventures that Cydan created; he was also on the venture team at OrbiMed and is the co-founder and CSO of the Rare Genomics Institute, a nonprofit dedicated to helping rare disease patients. Listen for an in-depth dialogue on the strides our industry has made in how we discover and develop new therapies for rare diseases, and what may be on the horizon for investors, entrepreneurs, patients and their families.